A novel endothelial damage inhibitor for the treatment of vascular conduits in coronary artery bypass grafting: protocol and rationale for the European, multicentre, prospective, observational DuraGraft registry

Peer Review reports

Original Submission
7 Aug 2019	Submitted	Original manuscript
18 Aug 2019	Reviewed	Reviewer Report - Bil Kirmani
19 Aug 2019	Reviewed	Reviewer Report - Arndt Kiessling
22 Aug 2019	Reviewed	Reviewer Report - Antonio Lio
29 Aug 2019	Reviewed	Reviewer Report - Hiroshi Kubota
26 Sep 2019	Author responded	Author comments - Etem Caliskan
Resubmission - Version 2
26 Sep 2019	Submitted	Manuscript version 2
Publishing
30 Sep 2019	Editorially accepted
15 Oct 2019	Article published	10.1186/s13019-019-1010-z

Back to article page